Stifel Reiterates Buy Rating on Edwards Lifesciences (EW)

February 11, 2026 10:22 AM EST Send to a Friend
Stifel analyst Rick Wise reiterated a Buy rating and $110.00 price target on Edwards Lifesciences (NYSE: EW).The analyst commented, "Healthy ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login